Similar articles for PMID: 25550533

Year	Number of Results
1998	1
2003	1
2004	1
2006	1
2007	6
2008	3
2009	15
2010	14
2011	17
2012	12
2013	22
2014	16
2015	27
2016	30
2017	41
2018	38
2019	20
2020	26
2021	24
2022	21
2023	6

1

Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.

Chung SS, Vadgama JV. Chung SS, et al. Anticancer Res. 2015 Jan;35(1):39-46. Anticancer Res. 2015. PMID: 25550533 Free PMC article.

2

(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Li YJ, Wu SL, Lu SM, Chen F, Guo Y, Gan SM, Shi YL, Liu S, Li SL. Li YJ, et al. Tumour Biol. 2015 Apr;36(4):2747-61. doi: 10.1007/s13277-014-2899-4. Epub 2014 Dec 7. Tumour Biol. 2015. PMID: 25487615

3

Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.

Wubetu GY, Shimada M, Morine Y, Ikemoto T, Ishikawa D, Iwahashi S, Yamada S, Saito Y, Arakawa Y, Imura S. Wubetu GY, et al. J Gastroenterol Hepatol. 2016 Jan;31(1):256-64. doi: 10.1111/jgh.13069. J Gastroenterol Hepatol. 2016. PMID: 26241688

4

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.

Ibrahim SA, Gadalla R, El-Ghonaimy EA, Samir O, Mohamed HT, Hassan H, Greve B, El-Shinawi M, Mohamed MM, Götte M. Ibrahim SA, et al. Mol Cancer. 2017 Mar 7;16(1):57. doi: 10.1186/s12943-017-0621-z. Mol Cancer. 2017. PMID: 28270211 Free PMC article.

5

Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.

Wang S, Chen R, Zhong Z, Shi Z, Chen M, Wang Y. Wang S, et al. Am J Chin Med. 2014;42(5):1279-300. doi: 10.1142/S0192415X14500803. Am J Chin Med. 2014. PMID: 25242081

6

Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.

Lin C, Wang L, Wang H, Yang L, Guo H, Wang X. Lin C, et al. J Cell Biochem. 2013 Sep;114(9):2061-70. doi: 10.1002/jcb.24553. J Cell Biochem. 2013. PMID: 23553622

7

Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.

Pan X, Zhao B, Song Z, Han S, Wang M. Pan X, et al. J Pharmacol Sci. 2016 Feb;130(2):85-93. doi: 10.1016/j.jphs.2015.12.003. Epub 2015 Dec 15. J Pharmacol Sci. 2016. PMID: 26810571 Free article.

8

Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.

Hu C, Li M, Guo T, Wang S, Huang W, Yang K, Liao Z, Wang J, Zhang F, Wang H. Hu C, et al. Phytomedicine. 2019 May;58:152740. doi: 10.1016/j.phymed.2018.11.001. Epub 2018 Nov 12. Phytomedicine. 2019. PMID: 31005718

9

Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.

Lee SH, Nam HJ, Kang HJ, Kwon HW, Lim YC. Lee SH, et al. Eur J Cancer. 2013 Oct;49(15):3210-8. doi: 10.1016/j.ejca.2013.06.025. Epub 2013 Jul 19. Eur J Cancer. 2013. PMID: 23876835

10

Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.

Choi HS, Kim JH, Kim SL, Deng HY, Lee D, Kim CS, Yun BS, Lee DS. Choi HS, et al. Mol Carcinog. 2018 Nov;57(11):1467-1479. doi: 10.1002/mc.22870. Epub 2018 Jul 18. Mol Carcinog. 2018. PMID: 29964299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

305 results

Results by year